Unmapped specialty drug requests: cross-border specialty drug access for international patients

Quick orientation

This hub historically captured drug-condition requests that did not yet have a dedicated condition page. The volume is small and intentionally heterogeneous.

Typical age of onset. Variable.

Severity tiers. Variable.

Why specialty drugs for Unmapped specialty drug requests are hard to access internationally

Some FDA-approved specialty drugs map to conditions that fall between major therapeutic areas, or to indications where the global registration footprint is small. Reserve Meds reviews each request on a case-by-case basis and routes to the appropriate clinical and regulatory specialist.

Treatments approved by the FDA

• No FDA-approved targeted therapies for this condition are currently in our access catalog. Standard-of-care management continues with locally available agents.

Cross-border pathways used for Unmapped specialty drug requests

Most patients use one or more of the following regulatory pathways, depending on the destination country and the specific drug:

• Named Patient Program (NPP)
• Expanded Access Program (EAP)
• Compassionate Use
• Personal Import Scheme
• Cross-border Prescription

What your physician needs to know

• Provide the full drug name and indication.
• Provide the patient's diagnosis with ICD-10 where possible.
• Document prior therapy and clinical rationale for the requested drug.
• Confirm whether the destination country requires specialist co-sign.
• Reserve Meds clinical and regulatory team reviews and confirms feasibility.

Common questions

What if my drug or condition isn't on your site yet?

Submit a request. Our team reviews and confirms whether the drug is in our access catalog and the appropriate pathway for your destination country.

How long does review take?

Initial review typically completes within 2 to 5 business days.

Are there drugs you cannot supply?

We do not supply controlled substances or reverse-flow shipments to the US. Other product categories are evaluated case by case.

What documents are required?

Treating physician's prescription, clinical summary, and any destination-specific documentation.

Where Reserve Meds fits in

Reserve Meds is a cross-border specialty drug access platform. We support international patients whose prescribed FDA-approved medicine is not registered locally, is not reimbursed by their payer, or is otherwise unavailable through standard channels. For Unmapped specialty drug requests, our role is to coordinate the regulatory pathway, source the medicine from a DSCSA-compliant US wholesaler, and arrange validated cold-chain or controlled-temperature shipment to the destination country.

We do not replace your treating physician. We do not bill insurance. We operate a cash-pay model, and we work alongside the clinical team that knows your case. Every prescription is reviewed by a US-licensed pharmacist before dispense, and a US-licensed physician reviews the supply request before shipment.

Start a request

Request a drug for Unmapped specialty drug requests

Reserved for you.